Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Wilson

Showing results (11-20 of 424) with videos related to

Pageof 43
Sort By:
Progress in Cardiovascular Diseases|July 13, 2010
Preface-Global impact of the Framingham Heart StudyPeter W F Wilson
JAMA|June 19, 2008
CETP genes, metabolic effects, and coronary disease riskPeter W F Wilson
Current Treatment Options in Cardiovascular Medicine|October 14, 2006
Smoking, smoking cessation, and risk of cardiovascular diseasePeter W F Wilson
JACC. Cardiovascular Imaging|August 12, 2017
Development and Progression of Coronary Artery CalcificationPeter W F Wilson
Circulation|December 15, 2015
Changing Cholesterol Levels and Coronary Heart Disease RiskPeter W F Wilson
Current Cardiology Reports|October 16, 2002
Heart protection studyPeter W F Wilson
Current Cardiology Reports|October 16, 2002
Simvastatin and niacinPeter W F Wilson
Cardiology Clinics|January 25, 2011
Prediction of cardiovascular disease eventsPeter W F Wilson
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham viewPeter W F Wilson
Circulation|December 22, 2004
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paperPeter W F Wilson, ,
Pageof 43

Showing results (11-20 of 424) with videos related to

Sort By:
Pageof 43
Progress in Cardiovascular Diseases|July 13, 2010
Preface-Global impact of the Framingham Heart StudyPeter W F Wilson
JAMA|June 19, 2008
CETP genes, metabolic effects, and coronary disease riskPeter W F Wilson
Current Treatment Options in Cardiovascular Medicine|October 14, 2006
Smoking, smoking cessation, and risk of cardiovascular diseasePeter W F Wilson
JACC. Cardiovascular Imaging|August 12, 2017
Development and Progression of Coronary Artery CalcificationPeter W F Wilson
Circulation|December 15, 2015
Changing Cholesterol Levels and Coronary Heart Disease RiskPeter W F Wilson
Current Cardiology Reports|October 16, 2002
Heart protection studyPeter W F Wilson
Current Cardiology Reports|October 16, 2002
Simvastatin and niacinPeter W F Wilson
Cardiology Clinics|January 25, 2011
Prediction of cardiovascular disease eventsPeter W F Wilson
Endocrinology and Metabolism Clinics of North America|July 21, 2004
Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham viewPeter W F Wilson
Circulation|December 22, 2004
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: ability of inflammatory markers to predict disease in asymptomatic patients: a background paperPeter W F Wilson, ,
Pageof 43